• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SHMT2 通过调控 HIF1α/VEGF/STAT3 信号通路促进胃癌发展。

SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling.

机构信息

Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing 100050, China.

出版信息

Int J Mol Sci. 2023 Apr 12;24(8):7150. doi: 10.3390/ijms24087150.

DOI:10.3390/ijms24087150
PMID:37108312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10138966/
Abstract

The metabolic enzymes involved in one-carbon metabolism are closely associated with tumor progression and could be potential targets for cancer therapy. Recent studies showed that serine hydroxymethyltransferase 2 (SHMT2), a crucial enzyme in the one-carbon metabolic pathway, plays a key role in tumor proliferation and development. However, the precise role and function of SHMT2 in gastric cancer (GC) remain poorly understood. In this study, we presented evidence that SHMT2 was necessary for hypoxia-inducible factor-1α (HIF1α) stability and contributed to GC cells' hypoxic adaptation. The analysis of datasets retrieved from The Cancer Genome Atlas and the experimentation with human cell lines revealed a marked increase in SHMT2 expression in GC. The SHMT2 knockdown in MGC803, SGC7901, and HGC27 cell lines inhibited cell proliferation, colony formation, invasion, and migration. Notably, SHMT2 depletion disrupted redox homeostasis and caused glycolytic function loss in GC cells under hypoxic circumstances. Mechanistically, we discovered SHMT2 modulated HIF1α stability, which acted as a master regulator of hypoxia-inducible genes under hypoxic conditions. This, in turn, regulated the downstream VEGF and STAT3 pathways. The in vivo xenograft experiments showed that SHMT2 knockdown markedly reduced GC growth. Our results elucidate the novel function of SHMT2 in stabilizing HIF1α under hypoxic conditions, thus providing a potential therapeutic strategy for GC treatment.

摘要

一碳代谢中涉及的代谢酶与肿瘤的进展密切相关,可能成为癌症治疗的潜在靶点。最近的研究表明,丝氨酸羟甲基转移酶 2(SHMT2)作为一碳代谢途径中的关键酶,在肿瘤的增殖和发展中起着关键作用。然而,SHMT2 在胃癌(GC)中的确切作用和功能仍知之甚少。在这项研究中,我们提供了证据表明 SHMT2 对于缺氧诱导因子-1α(HIF1α)的稳定性是必需的,并有助于 GC 细胞的缺氧适应。从癌症基因组图谱(The Cancer Genome Atlas)中检索的数据集的分析和人类细胞系的实验表明,GC 中 SHMT2 的表达明显增加。在 MGC803、SGC7901 和 HGC27 细胞系中敲低 SHMT2 抑制了细胞增殖、集落形成、侵袭和迁移。值得注意的是,SHMT2 的耗竭破坏了 GC 细胞在缺氧条件下的氧化还原平衡,并导致糖酵解功能丧失。在机制上,我们发现 SHMT2 调节 HIF1α 的稳定性,HIF1α 作为缺氧诱导基因在缺氧条件下的主调控因子。这反过来又调节下游的 VEGF 和 STAT3 途径。体内异种移植实验表明,SHMT2 敲低显著降低了 GC 的生长。我们的研究结果阐明了 SHMT2 在缺氧条件下稳定 HIF1α 的新功能,为 GC 的治疗提供了一种潜在的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/241111c765c8/ijms-24-07150-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/c07d70aa8e43/ijms-24-07150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/027811a29d74/ijms-24-07150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/67302bac1e58/ijms-24-07150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/ad608ae2454d/ijms-24-07150-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/ba981d586f8b/ijms-24-07150-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/5fe42598c37b/ijms-24-07150-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/241111c765c8/ijms-24-07150-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/c07d70aa8e43/ijms-24-07150-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/027811a29d74/ijms-24-07150-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/67302bac1e58/ijms-24-07150-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/ad608ae2454d/ijms-24-07150-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/ba981d586f8b/ijms-24-07150-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/5fe42598c37b/ijms-24-07150-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58cb/10138966/241111c765c8/ijms-24-07150-g007.jpg

相似文献

1
SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling.SHMT2 通过调控 HIF1α/VEGF/STAT3 信号通路促进胃癌发展。
Int J Mol Sci. 2023 Apr 12;24(8):7150. doi: 10.3390/ijms24087150.
2
Serine catabolism regulates mitochondrial redox control during hypoxia.丝氨酸分解代谢在缺氧过程中调节线粒体氧化还原控制。
Cancer Discov. 2014 Dec;4(12):1406-17. doi: 10.1158/2159-8290.CD-14-0250. Epub 2014 Sep 3.
3
Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism.无 Drosha 依赖的 miR-6778-5p 通过调节细胞质一碳叶酸代谢来增强胃癌干细胞干性。
Cancer Lett. 2020 May 28;478:8-21. doi: 10.1016/j.canlet.2020.02.040. Epub 2020 Mar 4.
4
Serine hydroxymethyltransferase 2: a novel target for human cancer therapy.丝氨酸羟甲基转移酶 2:人类癌症治疗的新靶点。
Invest New Drugs. 2021 Dec;39(6):1671-1681. doi: 10.1007/s10637-021-01144-z. Epub 2021 Jul 3.
5
Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.细胞质 SHMT2 通过抑制β-连环蛋白降解促进结直肠癌的进展和转移。
Theranostics. 2021 Jan 1;11(6):2966-2986. doi: 10.7150/thno.48699. eCollection 2021.
6
Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.组蛋白甲基转移酶 SETD1A 与 HIF1α 相互作用,增强糖酵解,促进胃癌的癌症进展。
Mol Oncol. 2020 Jun;14(6):1397-1409. doi: 10.1002/1878-0261.12689. Epub 2020 Apr 26.
7
Metformin suppresses hypoxia‑induced migration via the HIF‑1α/VEGF pathway in gallbladder cancer in vitro and in vivo.二甲双胍通过 HIF-1α/VEGF 通路抑制胆囊癌细胞在体内外的缺氧诱导迁移。
Oncol Rep. 2018 Dec;40(6):3501-3510. doi: 10.3892/or.2018.6751. Epub 2018 Sep 28.
8
Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism.Shmt2:前列腺癌能量代谢中 Stat3 信号的新角色
Cells. 2019 Sep 6;8(9):1048. doi: 10.3390/cells8091048.
9
STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.STAT3 和 HIF1α 协同激活 MDA-MB-231 和 RCC4 细胞中的 HIF1 靶基因。
Oncogene. 2014 Mar 27;33(13):1670-9. doi: 10.1038/onc.2013.115. Epub 2013 Apr 22.
10
Hypoxia-inducible factor-1α and Wnt/β-catenin signaling pathways promote the invasion of hypoxic gastric cancer cells.缺氧诱导因子-1α与Wnt/β-连环蛋白信号通路促进缺氧胃癌细胞的侵袭。
Mol Med Rep. 2015 Sep;12(3):3365-3373. doi: 10.3892/mmr.2015.3812. Epub 2015 May 21.

引用本文的文献

1
New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic.神经内分泌前列腺癌潜在治疗靶点的新见解:从实验室到临床
Research (Wash D C). 2025 Jul 31;8:0791. doi: 10.34133/research.0791. eCollection 2025.
2
Design, Synthesis, Anti-Tumor Activity and Molecular Docking Studies of Novel Triphenylphosphine-Containing Formononetin Derivatives.新型含三苯基膦的芒柄花素衍生物的设计、合成、抗肿瘤活性及分子对接研究
Int J Mol Sci. 2025 May 30;26(11):5280. doi: 10.3390/ijms26115280.
3
Serine Hydroxymethyltransferase Modulates Midgut Physiology in Through miRNA Regulation: Insights from Small RNA Sequencing and Gene Expression Analysis.

本文引用的文献

1
Knockdown of SHMT2 enhances the sensitivity of gastric cancer cells to radiotherapy through the Wnt/β-catenin pathway.敲低丝氨酸羟甲基转移酶2(SHMT2)可通过Wnt/β-连环蛋白信号通路增强胃癌细胞对放疗的敏感性。
Open Life Sci. 2022 Sep 19;17(1):1249-1255. doi: 10.1515/biol-2022-0480. eCollection 2022.
2
SHMT2 Induces Stemness and Progression of Head and Neck Cancer.SHMT2 诱导头颈部癌症的干性和进展。
Int J Mol Sci. 2022 Aug 26;23(17):9714. doi: 10.3390/ijms23179714.
3
Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance.
丝氨酸羟甲基转移酶通过微小RNA调控调节中肠生理:来自小RNA测序和基因表达分析的见解
Biomolecules. 2025 Apr 30;15(5):644. doi: 10.3390/biom15050644.
4
Serine metabolism in tumor progression and immunotherapy.丝氨酸代谢在肿瘤进展和免疫治疗中的作用
Discov Oncol. 2025 Apr 28;16(1):628. doi: 10.1007/s12672-025-02358-w.
5
The role and research progress of serine metabolism in tumor cells.丝氨酸代谢在肿瘤细胞中的作用及研究进展
Front Oncol. 2025 Apr 8;15:1509662. doi: 10.3389/fonc.2025.1509662. eCollection 2025.
6
TFE3 and HIF1α regulates the expression of SHMT2 isoforms via alternative promoter utilization in ovarian cancer cells.在卵巢癌细胞中,TFE3和HIF1α通过选择性启动子利用来调控SHMT2亚型的表达。
Cell Death Dis. 2025 Mar 17;16(1):178. doi: 10.1038/s41419-025-07445-y.
7
Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review.靶向氨基酸代谢以抑制胃癌进展并促进抗肿瘤免疫:综述
Front Immunol. 2025 Feb 13;16:1508730. doi: 10.3389/fimmu.2025.1508730. eCollection 2025.
8
Induction, growth, drug resistance, and metastasis: A comprehensive summary of the relationship between STAT3 and gastric cancer.诱导、生长、耐药性及转移:STAT3与胃癌关系的全面综述
Heliyon. 2024 Sep 4;10(18):e37263. doi: 10.1016/j.heliyon.2024.e37263. eCollection 2024 Sep 30.
9
Establishment of a novel microfluidic co-culture system for simultaneous analysis of multiple indicators of gefitinib sensitivity in colorectal cancer cells.建立一种新型的微流控共培养系统,用于同时分析结直肠癌细胞中吉非替尼敏感性的多个指标。
Mikrochim Acta. 2024 Apr 22;191(5):279. doi: 10.1007/s00604-024-06362-9.
10
Phosphorylated SHMT2 Regulates Oncogenesis Through mA Modification in Lung Adenocarcinoma.磷酸化 SHMT2 通过 mA 修饰调控肺腺癌的发生。
Adv Sci (Weinh). 2024 May;11(18):e2307834. doi: 10.1002/advs.202307834. Epub 2024 Mar 9.
阻断甘氨酸利用通过破坏谷胱甘肽平衡来抑制多发性骨髓瘤的进展。
Nat Commun. 2022 Jul 11;13(1):4007. doi: 10.1038/s41467-022-31248-w.
4
SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells.SHMT2通过内在信号通路促进膀胱癌细胞的细胞活力,并抑制活性氧依赖性、线粒体介导的细胞凋亡。
Cancer Gene Ther. 2022 Oct;29(10):1514-1527. doi: 10.1038/s41417-022-00470-5. Epub 2022 Apr 14.
5
Advances in clinical immunotherapy for gastric cancer.胃癌临床免疫治疗进展。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188615. doi: 10.1016/j.bbcan.2021.188615. Epub 2021 Aug 14.
6
Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.胃神经内分泌癌、混合性腺神经内分泌癌和腺癌的生存和复发模式比较。
JAMA Netw Open. 2021 Jul 1;4(7):e2114180. doi: 10.1001/jamanetworkopen.2021.14180.
7
Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer.SHMT2的过表达预示膀胱癌预后不良并促进肿瘤细胞生长。
Front Genet. 2021 Jun 4;12:682856. doi: 10.3389/fgene.2021.682856. eCollection 2021.
8
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.一线纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌、胃食管交界癌和食管腺癌(CheckMate 649):一项随机、开放标签的3期试验。
Lancet. 2021 Jul 3;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2. Epub 2021 Jun 5.
9
Metabolic reprogramming and epigenetic modifications on the path to cancer.癌症发生过程中的代谢重编程和表观遗传修饰。
Protein Cell. 2022 Dec;13(12):877-919. doi: 10.1007/s13238-021-00846-7. Epub 2021 May 29.
10
The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.HIF-1α/ALYREF/PKM2 轴在膀胱癌糖酵解和肿瘤发生中的作用。
Cancer Commun (Lond). 2021 Jul;41(7):560-575. doi: 10.1002/cac2.12158. Epub 2021 May 15.